{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:04:35Z","timestamp":1792699475117,"version":"4.5.0"},"reference-count":130,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Mevalonate kinase deficiency (MKD) is an autoinflammatory metabolic disorder characterized by life-long recurring episodes of fever and inflammation, often without clear cause. MKD is caused by bi-allelic pathogenic variants in the\n                    <jats:italic>MVK<\/jats:italic>\n                    gene, resulting in a decreased activity of the encoded enzyme mevalonate kinase (MK). MK is an essential enzyme in the isoprenoid biosynthesis pathway, which generates both non-sterol and sterol isoprenoids. The inflammatory symptoms of patients with MKD point to a major role for isoprenoids in the regulation of the innate immune system. In particular a temporary shortage of the non-sterol isoprenoid geranylgeranyl pyrophosphate (GGPP) is increasingly linked with inflammation in MKD. The shortage of GGPP compromises protein prenylation, which is thought to be one of the main causes leading to the inflammatory episodes in MKD. In this review, we discuss current views and the state of knowledge of the pathogenetic mechanisms in MKD, with particular focus on the role of compromised protein prenylation.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2021.724991","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T04:19:53Z","timestamp":1630729193000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency"],"prefix":"10.3389","volume":"12","author":[{"given":"Frouwkje A.","family":"Politiek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans R.","family":"Waterham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.clim.2012.09.011","article-title":"Mevalonate Kinase Deficiency, a Metabolic Autoinflammatory Disease","volume":"147","author":"van der Burgh","year":"2013","journal-title":"Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/9696","article-title":"Mutations in the Gene Encoding Mevalonate Kinase Cause Hyper-IgD and Periodic Fever Syndrome","volume":"22","author":"Drenth","year":"1999","journal-title":"Nat Genet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/9691","article-title":"Mutations in MVK, Encoding Mevalonate Kinase, Cause Hyperimmunoglobulinaemia D and Periodic Fever Syndrome","volume":"22","author":"Houten","year":"1999","journal-title":"Nat Genet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198606193142504","article-title":"Mevalonic Aciduria \u2014 An Inborn Error of Cholesterol and Nonsterol Isoprene Biosynthesis","volume":"314","author":"Hoffmann","year":"1986","journal-title":"New Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nrm.2016.67","article-title":"Regulating Rho GTPases and Their Regulators","volume":"17","author":"Hodge","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and Regulation of Cholesterol Homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2006.07.027","article-title":"Defects of Cholesterol Biosynthesis","volume":"580","author":"Waterham","year":"2006","journal-title":"FEBS Lett"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.03.002","article-title":"Autoinflammatory Disease Reloaded: A Clinical Perspective","volume":"140","author":"Kastner","year":"2010","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1542\/peds.91.5.915","article-title":"Clinical and Biochemical Phenotype in 11 Patients With Mevalonic Aciduria","volume":"91","author":"Hoffmann","year":"1993","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)42199-0","article-title":"Molecular Cloning of Human Mevalonate Kinase and Identification of a Missense Mutation in the Genetic Disease Mevalonic Aciduria","volume":"267","author":"Schafer","year":"1992","journal-title":"J Biol Chem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000115390.33405.F7","article-title":"Mevalonate Kinase Deficiency: Evidence for a Phenotypic Continuum","volume":"62","author":"Simon","year":"2004","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199405000-00002","article-title":"Hyperimmunoglobulinemia D and Periodic Fever Syndrome: The Clinical Spectrum in a Series of 50 Patients: The International Hyper-IgD Study Group","volume":"73","author":"Drenth","year":"1994","journal-title":"Medicine"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318190cfb7","article-title":"Long-Term Follow-Up, Clinical Features, and Quality of Life in a Series of 103 Patients With Hyperimmunoglobulinemia D Syndrome","volume":"87","author":"van der Hilst","year":"2008","journal-title":"Medicine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/art.39763","article-title":"The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry","volume":"68","author":"ter Haar","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/humu.20361","article-title":"Mutational Spectrum and Genotype-Phenotype Correlations in Mevalonate Kinase Deficiency","volume":"27","author":"Mandey","year":"2006","journal-title":"Hum Mutat"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.25.3115","article-title":"Temperature Dependence of Mutant Mevalonate Kinase Activity as a Pathogenic Factor in Hyper-IgD and Periodic Fever Syndrome","volume":"11","author":"Houten","year":"2002","journal-title":"Hum Mol Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/BF01800016","article-title":"Mevalonate Kinase Assay Using DEAE-Cellulose Column Chromatography for First-Trimester Prenatal Diagnosis and Complementation Analysis in Mevalonic Aciduria","volume":"15","author":"Hoffmann","year":"1992","journal-title":"J Inherit Metab Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200614","article-title":"Molecular Analysis of MVK Mutations and Enzymatic Activity in Hyper-IgD and Periodic Fever Syndrome","volume":"9","author":"Cuisset","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-3639","article-title":"Mevalonate Kinase Deficiency: A Survey of 50 Patients","volume":"128","author":"Bader-Meunier","year":"2011","journal-title":"Pediatrics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206564200","article-title":"Regulation of Isoprenoid\/Cholesterol Biosynthesis in Cells From Mevalonate Kinase-Deficient Patients","volume":"278","author":"Houten","year":"2003","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3390\/jcm10081552","article-title":"Mevalonate Kinase-Associated Diseases: Hunting for Phenotype\u2013Genotype Correlation","volume":"10","author":"Boursier","year":"2021","journal-title":"J Clin Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/343425a0","article-title":"Regulation of the Mevalonate Pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2015.11","article-title":"Protein Prenylation: Unique Fats Make Their Mark on Biology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-005-5298-6","article-title":"Isoprenylated Proteins","volume":"63","author":"McTaggart","year":"2006","journal-title":"Cell Mol Life Sci CMLS"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: Activators of the Complete Program of Cholesterol and Fatty Acid Synthesis in the Liver","volume":"109","author":"Horton","year":"2002","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1146\/annurev-biochem-062917-011852","article-title":"Retrospective on Cholesterol Homeostasis: The Central Role of Scap","volume":"87","author":"Brown","year":"2018","journal-title":"Annu Rev Biochem"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.RA119000201","article-title":"Endogenous Sterol Intermediates of the Mevalonate Pathway Regulate HMGCR Degradation and SREBP-2 Processing[s]","volume":"60","author":"Chen","year":"2019","journal-title":"J Lipid Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M004793200","article-title":"The Ubiquitin-Proteasome Pathway Mediates the Regulated Degradation of Mammalian 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase*","volume":"275","author":"Ravid","year":"2000","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310053200","article-title":"Insig-Dependent Ubiquitination and Degradation of Mammalian 3-Hydroxy-3-Methylglutaryl-CoA Reductase Stimulated by Sterols and Geranylgeraniol","volume":"278","author":"Sever","year":"2003","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1097-2765(02)00822-5","article-title":"Accelerated Degradation of HMG CoA Reductase Mediated by Binding of Insig-1 to Its Sterol-Sensing Domain","volume":"11","author":"Sever","year":"2003","journal-title":"Mol Cell"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2005.01.001","article-title":"Insig-Mediated Degradation of HMG CoA Reductase Stimulated by Lanosterol, An Intermediate in the Synthesis of Cholesterol","volume":"1","author":"Song","year":"2005","journal-title":"Cell Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)37422-7","article-title":"Non-Sterol Compounds That Regulate Cholesterogenesis. Analogues of Farnesyl Pyrophosphate Reduce 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Levels","volume":"269","author":"Bradfute","year":"1994","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)42221-7","article-title":"Multivalent Feedback Regulation of HMG CoA Reductase, a Control Mechanism Coordinating Isoprenoid Synthesis and Cell Growth","volume":"21","author":"Brown","year":"1980","journal-title":"J Lipid Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)32450-X","article-title":"Identification of Farnesol as the non-Sterol Derivative of Mevalonic Acid Required for the Accelerated Degradation of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase","volume":"269","author":"Correll","year":"1994","journal-title":"J Biol Chem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.14.7916","article-title":"Regulation of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Degradation by the Nonsterol Mevalonate Metabolite Farnesol In Vivo","volume":"271","author":"Meigs","year":"1996","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/abbi.1997.0200","article-title":"Farnesol as a Regulator of HMG-CoA Reductase Degradation: Characterization and Role of Farnesyl Pyrophosphatase","volume":"345","author":"Meigs","year":"1997","journal-title":"Arch Biochem Biophys"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M068759","article-title":"Geranylgeranyl-Regulated Transport of the Prenyltransferase UBIAD1 Between Membranes of the ER and Golgi[s]","volume":"57","author":"Schumacher","year":"2016","journal-title":"J Lipid Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)68397-8","article-title":"Multivalent Control of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase. Mevalonate-Derived Product Inhibits Translation of mRNA and Accelerates Degradation of Enzyme","volume":"263","author":"Nakanishi","year":"1988","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199308000-00004","article-title":"Decreased Plasma Ubiquinone-10 Concentration in Patients With Mevalonate Kinase Deficiency","volume":"34","author":"H\u00fcbner","year":"1993","journal-title":"Pediatr Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(85)90195-0","article-title":"Mevalonic Aciduria: An Inborn Error of Cholesterol Biosynthesis","volume":"152","author":"Berger","year":"1985","journal-title":"Clin Chim Acta"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-009-1150-8","article-title":"Coenzyme Q10 Is Decreased in Fibroblasts of Patients With Methylmalonic Aciduria But Not in Mevalonic Aciduria","volume":"32","author":"Haas","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01359.x","article-title":"Effect of Inflammatory Attacks in the Classical Type Hyper-IgD Syndrome on Immunoglobulin D, Cholesterol and Parameters of the Acute Phase Response","volume":"256","author":"Simon","year":"2004","journal-title":"J Internal Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.3777","article-title":"The Monogenic Autoinflammatory Diseases Define New Pathways in Human Innate Immunity and Inflammation","volume":"18","author":"Manthiram","year":"2017","journal-title":"Nat Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cmet.2017.06.018","article-title":"Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control","volume":"26","author":"Pr\u00f3chnicki","year":"2017","journal-title":"Cell Metab"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00865","article-title":"Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide","volume":"11","author":"Soriano","year":"2020","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.12.3586.bloodjournal85123586","article-title":"Cytokine Activation During Attacks of the Hyperimmunoglobulinemia D and Periodic Fever Syndrome","volume":"85","author":"Drenth","year":"1995","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.157.1.400","article-title":"Unstimulated Peripheral Blood Mononuclear Cells From Patients With the Hyper-IgD Syndrome Produce Cytokines Capable of Potent Induction of C-Reactive Protein and Serum Amyloid A in Hep3B Cells","volume":"157","author":"Drenth","year":"1996","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/13506120500106982","article-title":"Serum Amyloid A Serum Concentrations and Genotype do Not Explain Low Incidence of Amyloidosis in Hyper-IgD Syndrome","volume":"12","author":"van der Hilst","year":"2005","journal-title":"Amyloid"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem200","article-title":"Diagnostic Value of Serum Immunoglobulinaemia D Level in Patients With a Clinical Suspicion of Hyper IgD Syndrome","volume":"46","author":"Ammouri","year":"2007","journal-title":"Rheumatology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/art.10550","article-title":"Lack of Isoprenoid Products Raises Ex Vivo Interleukin-1\u03b2 Secretion in Hyperimmunoglobulinemia D and Periodic Fever Syndrome","volume":"46","author":"Frenkel","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/art.22194","article-title":"A Role for Geranylgeranylation in Interleukin-1\u03b2 Secretion","volume":"54","author":"Mandey","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu341","article-title":"TLR2\/TLR4-Dependent Exaggerated Cytokine Production in Hyperimmunoglobulinaemia D and Periodic Fever Syndrome","volume":"54","author":"Stoffels","year":"2015","journal-title":"Rheumatology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","article-title":"Metabolic Induction of Trained Immunity Through the Mevalonate Pathway","volume":"172","author":"Bekkering","year":"2018","journal-title":"Cell"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining Trained Immunity and its Role in Health and Disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9173-8","article-title":"Compromized Geranylgeranylation of RhoA and Rac1 in Mevalonate Kinase Deficiency","volume":"33","author":"Henneman","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-144667","article-title":"HMG-CoA Reductase Inhibition Induces IL-1\u03b2 Release Through Rac1\/PI3K\/PKB-Dependent Caspase-1 Activation","volume":"112","author":"Kuijk","year":"2008","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.571810","article-title":"Unprenylated RhoA Contributes to IL-1beta Hypersecretion in Mevalonate Kinase Deficiency Model Through Stimulation of Rac1 Activity","volume":"289","author":"van der Burgh","year":"2014","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1038\/s41467-019-11606-x","article-title":"Protein Prenylation Restrains Innate Immunity by Inhibiting Rac1 Effector Interactions","volume":"10","author":"Akula","year":"2019","journal-title":"Nat Commun"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1172\/JCI43758","article-title":"Geranylgeranyltransferase Type I (GGTase-I) Deficiency Hyperactivates Macrophages and Induces Erosive Arthritis in Mice","volume":"121","author":"Khan","year":"2011","journal-title":"J Clin Invest"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190147","article-title":"A Novel Disorder Involving Dyshematopoiesis, Inflammation, and HLH Due to Aberrant CDC42 Function","volume":"216","author":"Lam","year":"2019","journal-title":"J Exp Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2017.12.015","article-title":"Functional Dysregulation of CDC42 Causes Diverse Developmental Phenotypes","volume":"102","author":"Martinelli","year":"2018","journal-title":"Am J Hum Genet"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jaci.2020.03.020","article-title":"A Toxic Palmitoylation of Cdc42 Enhances NF-\u03bab Signaling and Drives a Severe Autoinflammatory Syndrome","volume":"146","author":"Bekhouche","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.jaci.2019.06.017","article-title":"Severe Autoinflammation in 4 Patients With C-Terminal Variants in Cell Division Control Protein 42 Homolog (CDC42) Successfully Treated With IL-1\u03b2 Inhibition","volume":"144","author":"Gernez","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R500017-JLR200","article-title":"Thematic Review Series: Lipid Posttranslational Modifications. Geranylgeranylation of Rab GTPases","volume":"47","author":"Leung","year":"2006","journal-title":"J Lipid Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01900","article-title":"Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency","volume":"10","author":"Munoz","year":"2019","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2016.58","article-title":"Mevalonate Kinase Deficiency Leads to Decreased Prenylation of Rab GTPases","volume":"94","author":"Jurczyluk","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00435","article-title":"Rab GTPases in Immunity and Inflammation","volume":"7","author":"Prashar","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01745","article-title":"The Pyrin Inflammasome in Health and Disease","volume":"10","author":"Schnappauf","year":"2019","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nature13449","article-title":"Innate Immune Sensing of Bacterial Modifications of Rho GTPases by the Pyrin Inflammasome","volume":"513","author":"Xu","year":"2014","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3487","article-title":"Control of the Innate Immune Response by the Mevalonate Pathway","volume":"17","author":"Akula","year":"2016","journal-title":"Nat Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3457","article-title":"Pyrin Inflammasome Activation and RhoA Signaling in the Autoinflammatory Diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nat Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/ncb773","article-title":"Nucleotide Exchange Factor GEF-H1 Mediates Cross-Talk Between Microtubules and the Actin Cytoskeleton","volume":"4","author":"Krendel","year":"2002","journal-title":"Nat Cell Biol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.jaci.2019.02.013","article-title":"Lack of Protein Prenylation Promotes NLRP3 Inflammasome Assembly in Human Monocytes","volume":"143","author":"Skinner","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12950-015-0048-5","article-title":"Knockdown of MVK Does Not Lead to Changes in NALP3 Expression or Activation","volume":"12","author":"Celsi","year":"2015","journal-title":"J Inflammation"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2010.9","article-title":"The Inhibition of Mevalonate Pathway Induces Upregulation of NALP3 Expression: New Insight in the Pathogenesis of Mevalonate Kinase Deficiency","volume":"18","author":"Pontillo","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160716067","article-title":"Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible Link","volume":"16","author":"Tricarico","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2015.03.004","article-title":"Mitochondria in Autoinflammation: Cause, Mediator or Bystander","volume":"26","author":"van der Burgh","year":"2015","journal-title":"Trends Endocrinol Metabol: TEM"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.536920","article-title":"Defects in Mitochondrial Clearance Predispose Human Monocytes to Interleukin-1beta Hypersecretion","volume":"289","author":"van der Burgh","year":"2014","journal-title":"J Biol Chem"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1159\/000471235","article-title":"Lack of Prenylated Proteins, Autophagy Impairment and Apoptosis in SH-SY5Y Neuronal Cell Model of Mevalonate Kinase Deficiency","volume":"41","author":"Tricarico","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-039578","article-title":"Defective Apoptosis of Peripheral-Blood Lymphocytes in Hyper-IgD and Periodic Fever Syndrome","volume":"109","author":"Bodar","year":"2006","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/art.21657","article-title":"Neutrophils From Patients With TNFRSF1A Mutations Display Resistance to Tumor Necrosis Factor\u2013Induced Apoptosis: Pathogenetic and Clinical Implications","volume":"54","author":"D'Osualdo","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209335","article-title":"Canakinumab Reverses Overexpression of Inflammatory Response Genes in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome","volume":"76","author":"Torene","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15073","article-title":"Oxysterols: From Physiological Tuners to Pharmacological Opportunities","volume":"178","author":"Brown","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1126\/science.1254790","article-title":"25-Hydroxycholesterol Suppresses Interleukin-1\u2013Driven Inflammation Downstream of Type I Interferon","volume":"345","author":"Reboldi","year":"2014","journal-title":"Science"},{"key":"B86","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.biocel.2017.09.007","article-title":"25-Hydroxycholesterol and Inflammation in Lovastatin-Deregulated Mevalonate Pathway","volume":"92","author":"Tricarico","year":"2017","journal-title":"Int J Biochem Cell Biol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.020","article-title":"IL-10 Family Cytokines IL-10 and IL-22: From Basic Science to Clinical Translation","volume":"50","author":"Ouyang","year":"2019","journal-title":"Immunity"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17179-4","article-title":"Cholesterol Metabolism Drives Regulatory B Cell IL-10 Through Provision of Geranylgeranyl Pyrophosphate","volume":"11","author":"Bibby","year":"2020","journal-title":"Nat Commun"},{"key":"B89","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41467-019-08332-9","article-title":"The Cholesterol Biosynthesis Pathway Regulates IL-10 Expression in Human Th1 Cells","volume":"10","author":"Perucha","year":"2019","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01150","article-title":"Management of Mevalonate Kinase Deficiency: A Pediatric Perspective","volume":"11","author":"Jeyaratnam","year":"2020","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201268","article-title":"Treatment of Autoinflammatory Diseases: Results From the Eurofever Registry and a Literature Review","volume":"72","author":"ter Haar","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes","volume":"378","author":"De Benedetti","year":"2018","journal-title":"New Engl J Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/art.40146","article-title":"Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome","volume":"69","author":"Arostegui","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170684","article-title":"Efficacy of Continuous Interleukin 1 Blockade in Mevalonate Kinase Deficiency: A Multicenter Retrospective Study in 13 Adult Patients and Literature Review","volume":"45","author":"Deshayes","year":"2018","journal-title":"J Rheumatol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes097","article-title":"Efficacy of Interleukin-1-Targeting Drugs in Mevalonate Kinase Deficiency","volume":"51","author":"Galeotti","year":"2012","journal-title":"Rheumatology"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.619257","article-title":"IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives","volume":"11","author":"Malcova","year":"2021","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological Inhibitors of the NLRP3 Inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front Immunol"},{"key":"B98","article-title":"Therapeutic Blockade of Interleukin-6 by Tocilizumab in the Management of AA Amyloidosis and Chronic Inflammatory Disorders: A Case Series and Review of the Literature","volume":"33","author":"Lane","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"bcr2015210513","DOI":"10.1136\/bcr-2015-210513","article-title":"Anti-Interleukin 6 Receptor Therapy for Hyper-IgD Syndrome","volume":"2015","author":"Musters","year":"2015","journal-title":"BMJ Case Rep"},{"key":"B100","doi-asserted-by":"publisher","first-page":"3514645","DOI":"10.1155\/2018\/3514645","article-title":"Tocilizumab for the Treatment of Mevalonate Kinase Deficiency","volume":"2018","author":"Rafiq","year":"2018","journal-title":"Case Rep Pediatr"},{"key":"B101","doi-asserted-by":"publisher","first-page":"103-5","DOI":"10.1097\/01.RHU.0000442576.41537.de","article-title":"Interleukin 6 Blockade for Hyperimmunoglobulin D and Periodic Fever Syndrome","volume":"20","author":"Shendi","year":"2014","journal-title":"JCR: J Clin Rheumatol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23120","article-title":"International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency\/Hyperimmunoglobulinemia D Syndrome","volume":"69","author":"Ozen","year":"2017","journal-title":"Arthritis Care Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc072018","article-title":"Mevalonic Aciduria Cured by Bone Marrow Transplantation","volume":"357","author":"Arkwright","year":"2007","journal-title":"New Engl J Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03989.x","article-title":"Liver Transplantation Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Atypical Mevalonic Aciduria","volume":"12","author":"Chaudhury","year":"2012","journal-title":"Am J Transplant"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-2553","article-title":"Long-Term Outcome of a Successful Cord Blood Stem Cell Transplant in Mevalonate Kinase Deficiency","volume":"135","author":"Giardino","year":"2015","journal-title":"Pediatrics"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070715","article-title":"Allogeneic Bone Marrow Transplantation in Mevalonic Aciduria","volume":"356","author":"Neven","year":"2007","journal-title":"New Engl J Med"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-016-3456-9","article-title":"Massive Ascites in a Canakinumab Resistant Case With MVA Leading to Bone Marrow Transplantation","volume":"36","author":"Erdol","year":"2016","journal-title":"Rheumatol Int"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e13604","DOI":"10.1111\/petr.13604","article-title":"Mevalonic Aciduria: Does Stem Cell Transplant Fully Cure Disease","volume":"24","author":"Szymanski","year":"2020","journal-title":"Pediatr Transplant"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa912","article-title":"Haploidentical \u03b1\/\u03b2 T-Cell and B-Cell Depleted Stem Cell Transplantation in Severe Mevalonate Kinase Deficiency","author":"Faraci","year":"2021","journal-title":"Rheumatology"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.01.012","article-title":"Simvastatin Treatment for Inflammatory Attacks of the Hyperimmunoglobulinemia D and Periodic Fever Syndrome","volume":"75","author":"Simon","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.046542","article-title":"Dietary Geranylgeranyl Pyrophosphate Counteracts the Benefits of Statin Therapy in Experimental Pulmonary Hypertension","volume":"143","author":"Zhu","year":"2021","journal-title":"Circulation"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2021.104975","article-title":"A Toxicological Evaluation of Geranylgeraniol","volume":"104975","author":"Preece","year":"2021","journal-title":"Regul Toxicol Pharmacol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/art.21960","article-title":"Manipulation of Isoprenoid Biosynthesis as a Possible Therapeutic Option in Mevalonate Kinase Deficiency","volume":"54","author":"Schneiders","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1186\/s40064-016-3125-1","article-title":"Anti-Inflammatory and Cytoprotective Effects of a Squalene Synthase Inhibitor, TAK-475 Active Metabolite-I, in Immune Cells Simulating Mevalonate Kinase Deficiency (MKD)-Like Condition","volume":"5","author":"Suzuki","year":"2016","journal-title":"SpringerPlus"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.975284","article-title":"Lapaquistat Acetate: Development of a Squalene Synthase Inhibitor for the Treatment of Hypercholesterolemia","volume":"123","author":"Stein","year":"2011","journal-title":"Circulation"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2409","article-title":"Exome Sequencing Identifies MVK Mutations in Disseminated Superficial Actinic Porokeratosis","volume":"44","author":"Zhang","year":"2012","journal-title":"Nat Genet"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14343","article-title":"Mutations in Mevalonate Pathway Genes in Patients With Familial or Sporadic Porokeratosis","volume":"45","author":"Leng","year":"2018","journal-title":"J Dermatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1136\/jmedgenet-2014-102486","article-title":"Exome Sequencing Identifies SLC17A9 Pathogenic Gene in Two Chinese Pedigrees With Disseminated Superficial Actinic Porokeratosis","volume":"51","author":"Cui","year":"2014","journal-title":"J Med Genet"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e06322","DOI":"10.7554\/eLife.06322","article-title":"Genomic Variations of the Mevalonate Pathway in Porokeratosis","volume":"4","author":"Zhang","year":"2015","journal-title":"eLife"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13653","article-title":"Mutations in the Mevalonate Pathway Genes in Chinese Patients With Porokeratosis","volume":"30","author":"Li","year":"2016","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.05.020","article-title":"Clonal Expansion of Second-Hit Cells With Somatic Recombinations or C>T Transitions Form Porokeratosis in MVD or MVK Mutant Heterozygotes","volume":"139","author":"Kubo","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8569","article-title":"Effects of Mevalonate Kinase Interference on Cell Differentiation, Apoptosis, Prenylation and Geranylgeranylation of Human Keratinocytes Are Attenuated by Farnesyl Pyrophosphate or Geranylgeranyl Pyrophosphate","volume":"19","author":"Li","year":"2020","journal-title":"Exp Ther Med"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-Syndromic Retinitis Pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog Retinal Eye Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1080\/13816810.2016.1227459","article-title":"Mevalonate Kinase Deficiency Associated With Ataxia and Retinitis Pigmentosa in Two Brothers With MVK Gene Mutations","volume":"38","author":"Kellner","year":"2017","journal-title":"Ophthalmic Genet"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.07.052","article-title":"Mutations in the Mevalonate Kinase (MVK) Gene Cause Nonsyndromic Retinitis Pigmentosa","volume":"120","author":"Siemiatkowska","year":"2013","journal-title":"Ophthalmology"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-005-0178-7","article-title":"Retinitis Pigmentosa in Mevalonate Kinase Deficiency","volume":"28","author":"Balgobind","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.2.258","article-title":"Mevalonate Kinase Deficiency: Enlarging the Clinical and Biochemical Spectrum","volume":"111","author":"Prietsch","year":"2003","journal-title":"Pediatrics"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303956","article-title":"Monogenic Diseases Associated With Intestinal Inflammation: Implications for the Understanding of Inflammatory Bowel Disease","volume":"62","author":"Uhlig","year":"2013","journal-title":"Gut"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-306555","article-title":"Mevalonate Kinase Deficiency and IBD: Shared Genetic Background","volume":"63","author":"Bianco","year":"2014","journal-title":"Gut"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170911161417","article-title":"Repositioning of TAK-475 in Mevalonate Kinase Disease: Translating Theory Into Practice","volume":"25","author":"Marcuzzi","year":"2018","journal-title":"Curr Med Chem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.724991\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T11:16:10Z","timestamp":1673176570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.724991\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":130,"alternative-id":["10.3389\/fimmu.2021.724991"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.724991","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"article-number":"724991"}}